cetirizine has been researched along with Basophilic Leukemia, Acute in 2 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasan, S | 1 |
| Al Ali, H | 1 |
| Al-Qubaisi, M | 1 |
| Zobir Hussein, M | 1 |
| Ismail, M | 1 |
| Zainal, Z | 1 |
| Nazrul Hakim, M | 1 |
| Fischer, MJ | 1 |
| Paulussen, JJ | 1 |
| Horbach, DA | 1 |
| Roelofsen, EP | 1 |
| van Miltenburg, JC | 1 |
| de Mol, NJ | 1 |
| Janssen, LH | 1 |
2 other studies available for cetirizine and Basophilic Leukemia, Acute
| Article | Year |
|---|---|
Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells.
Topics: Adsorption; Animals; Cell Death; Cell Line, Tumor; Cell Survival; Cetirizine; Delayed-Action Prepara | 2012 |
Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antigens; Astemizole; beta-N-Acetylhexosaminidases; Cal | 1995 |